Biofrontera AG
BIFRF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 12.27M | 30.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 12.27M | 30.06M |
| Cost of Revenue | -- | -- | -- | 1.45M | 5.88M |
| Gross Profit | -- | -- | -- | 10.82M | 24.19M |
| SG&A Expenses | -- | -- | -- | 9.95M | 14.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 12.34M | 28.30M |
| Operating Income | -- | -- | -- | -68.10K | 1.77M |
| Income Before Tax | -- | -- | -- | 1.57M | -9.56M |
| Income Tax Expenses | -- | -- | -- | -- | 1.32M |
| Earnings from Continuing Operations | -- | -- | -- | 4.23 | -10.88 |
| Earnings from Discontinued Operations | -- | -- | -- | 951.30K | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -886.70K | -10.88M |
| EBIT | -- | -- | -- | -68.10K | 1.77M |
| EBITDA | -- | -- | -- | 302.30K | 2.14M |
| EPS Basic | -- | -- | -- | -0.85 | -3.72 |
| Normalized Basic EPS | -- | -- | -- | -0.28 | -2.02 |
| EPS Diluted | -- | -- | -- | -0.85 | -3.75 |
| Normalized Diluted EPS | -- | -- | -- | -0.28 | -2.02 |
| Average Basic Shares Outstanding | -- | -- | -- | 20.88M | 11.56M |
| Average Diluted Shares Outstanding | -- | -- | -- | 20.88M | 11.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |